Terms: = Ovarian cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Prognosis
117 results:
1. Effects of epidural anesthesia on the prognosis of ovarian cancer-a systematic review and meta-analysis.
Shen H; Pang Q; Gao Y; Liu H
BMC Anesthesiol; 2023 Nov; 23(1):390. PubMed ID: 38030996
[TBL] [Abstract] [Full Text] [Related]
2. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
J Gynecol Oncol; 2023 Sep; 34(5):e85. PubMed ID: 37593813
[TBL] [Abstract] [Full Text] [Related]
3. The holistic management of malignant bowel obstruction in women with advanced ovarian cancer at end of life.
Gaughan S; Williams M
Br J Nurs; 2023 Jun; 32(12):550-555. PubMed ID: 37344127
[TBL] [Abstract] [Full Text] [Related]
4. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
Int J Gynaecol Obstet; 2023 Aug; 162(2):383-394. PubMed ID: 37337978
[TBL] [Abstract] [Full Text] [Related]
5. Gynecological cancer prognosis using machine learning techniques: A systematic review of the last three decades (1990-2022).
Sheehy J; Rutledge H; Acharya UR; Loh HW; Gururajan R; Tao X; Zhou X; Li Y; Gurney T; Kondalsamy-Chennakesavan S
Artif Intell Med; 2023 May; 139():102536. PubMed ID: 37100507
[TBL] [Abstract] [Full Text] [Related]
6. Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group.
Wimberger P; Pfisterer J; du Bois A; Hilpert F; Kerkmann M; Sehouli J; Mahner S; de Gregorio N; Hanker L; Heitz F; Marmé F; Woelber L; Holtmann L; Elser G; Harter P;
Int J Gynecol Cancer; 2023 Jul; 33(7):1083-1089. PubMed ID: 37001891
[TBL] [Abstract] [Full Text] [Related]
7. cancer-associated spinal cord infarction: A systematic review and analysis of survival predictors.
Puente-Hernandez M; Rivero-de-Aguilar A; Varela-Lema L
J Neurol Sci; 2023 Mar; 446():120580. PubMed ID: 36764185
[TBL] [Abstract] [Full Text] [Related]
8. External Validation of the ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International ovarian Tumor Analysis 2-Step Strategy to Stratify ovarian Tumors Into O-RADS Risk Groups.
Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
[TBL] [Abstract] [Full Text] [Related]
9. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
[TBL] [Abstract] [Full Text] [Related]
10. A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer.
Zong S; Xu PP; Xu YH; Guo Y
J Ovarian Res; 2022 Aug; 15(1):90. PubMed ID: 35915456
[TBL] [Abstract] [Full Text] [Related]
11. PD-L1 and the Clinical Outcomes of ovarian cancer: meta-Analysis and Bioinformatical Analysis.
Shi X; Yun L; Chaoqun Liu L; Ding H; Liang D; Geng F; Yu H; Ban J; Li J; Jiang T; Sun Y
Asian Pac J Cancer Prev; 2022 Jul; 23(7):2285-2290. PubMed ID: 35901333
[TBL] [Abstract] [Full Text] [Related]
12. Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-met-PI3K/Akt-miR-199a-3p signaling pathway.
Hassan AA; Artemenko M; Tang MKS; Shi Z; Chen LY; Lai HC; Yang Z; Shum HC; Wong AST
Cell Death Dis; 2022 Jun; 13(6):537. PubMed ID: 35676254
[TBL] [Abstract] [Full Text] [Related]
13. Microsatellite instability as a marker of prognosis: a systematic review and meta-analysis of endometrioid endometrial cancer survival data.
Xiao JP; Wang JS; Zhao YY; Du J; Wang YZ
Arch Gynecol Obstet; 2023 Feb; 307(2):573-582. PubMed ID: 35665848
[TBL] [Abstract] [Full Text] [Related]
14. Role of tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: Systematic review and meta-analysis.
Guida F; Dioun S; Fagotti A; Melamed A; Grossi A; Scambia G; Wright JD; Tergas AI
Gynecol Oncol; 2022 Jul; 166(1):181-187. PubMed ID: 35550711
[TBL] [Abstract] [Full Text] [Related]
15. Stratified follow-up for endometrial cancer: a move to more personalized cancer care.
Sarwar A; Van Griethuysen J; Waterhouse J; Dehbi HM; Eminowicz G; McCormack M
Int J Gynecol Cancer; 2021 Dec; 31(12):1564-1571. PubMed ID: 34795021
[TBL] [Abstract] [Full Text] [Related]
16. Copper content in ascitic fluid is associated with angiogenesis and progression in ovarian cancer.
Onuma T; Mizutani T; Fujita Y; Yamada S; Yoshida Y
J Trace Elem Med Biol; 2021 Dec; 68():126865. PubMed ID: 34601284
[TBL] [Abstract] [Full Text] [Related]
17. Overexpression of Epithelial Splicing Regulatory Protein 1 in metastatic Lesions of Serous ovarian Carcinoma Correlates with Poor Patient prognosis.
Lu X; Li R; Wang X; Guo Q; Wang L; Zhou X
Cancer Biother Radiopharm; 2022 Nov; 37(9):850-861. PubMed ID: 34495766
[No Abstract] [Full Text] [Related]
18. Non-Surgical Management of Malignant Bowel Obstruction in Advanced ovarian cancer patients: A Systematic Review and meta-Analysis.
Idaikkadar P; Georgiou A; Skene S; Michael A
Am J Hosp Palliat Care; 2022 Jul; 39(7):838-846. PubMed ID: 34490792
[TBL] [Abstract] [Full Text] [Related]
19. Prediagnosis and postdiagnosis leisure time physical activity and survival following diagnosis with ovarian cancer.
Wang T; Townsend MK; Eliassen AH; Terry KL; Song M; Irwin ML; Tworoger SS
Int J Cancer; 2021 Sep; 149(5):1067-1075. PubMed ID: 33963766
[TBL] [Abstract] [Full Text] [Related]
20. Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer.
Fleming ND; Westin SN; Rauh-Hain JA; Soliman PT; Fellman BM; Coleman RL; Meyer LA; Shafer A; Cobb LP; Jazaeri A; Lu KH; Sood AK
Gynecol Oncol; 2021 Jul; 162(1):65-71. PubMed ID: 33838925
[TBL] [Abstract] [Full Text] [Related]
[Next]
